Just on valuation this what we know so farcurrent revenues from...

Just on valuation this what we know so far

current revenues from monitoring and services = USD 5mio annual

McDade estimated Q1 testing and pathology = USD30mio extrapolate * 4 = USD$120mio p.a

Serology agreement estimated monthly revenue of USD$4mio *12 = USD$48mio p.a

IF all this comes to fruition on a 10x revenue to price estimate let’s say $150mio x10 or $1.5bio in market cap

$1.5bio / 13.5mio shares on issue (not accounting for convertible note dilution) = $111per share

take with a huge grain of salt given execution track record and previous announcements that eventuate into nothing but seemingly this stock would be massively discounted to announced earnings

keep in mind false and misleading statements are securities fraud and carry up to 3 years jail + $10mio fine